CALITHERA BIOSCIENCES

calithera-biosciences-logo

Calithera Biosciences is a development-stage pharmaceutical company committed to discovering and developing novel small molecule therapeutics for the treatment of cancer. They are applying Their scientific expertise to build a pipeline of unique anti- cancer drugs that selectively target metabolic and apoptotic pathways critical to tumor growth and survival.

#People #Financial #Event #Website #More

CALITHERA BIOSCIENCES

Social Links:

Industry:
Biotechnology Pharmaceutical Therapeutics

Founded:
2010-06-01

Address:
South San Francisco, California, United States

Country:
United States

Website Url:
http://www.calithera.com

Total Employee:
101+

Status:
Active

Contact:
+1 650 870 1000

Email Addresses:
[email protected]

Total Funding:
291.4 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome



Current Advisors List

not_available_image

Ward Wolff Member Board Of Directors @ Calithera Biosciences
Board_member

deepika-r-pakianathan_image

Deepika R Pakianathan Board Member @ Calithera Biosciences
Board_member

jean-george_image

Jean George Member of the Board of Directors @ Calithera Biosciences
Board_member

ralph-christoffersen_image

Ralph Christoffersen Member of the Board of Directors @ Calithera Biosciences
Board_member

Current Employees Featured

susan-m-molineaux_image

Susan M. Molineaux
Susan M. Molineaux President and Chief Executive Officer @ Calithera Biosciences
President and Chief Executive Officer
2010-06-01

mike-ryan_image

Mike Ryan
Mike Ryan Advisor/Investor @ Calithera Biosciences
Advisor/Investor
2010-06-01

emil-t-kuriakose_image

Emil T. Kuriakose
Emil T. Kuriakose Vice President, Head of Clinical Development @ Calithera Biosciences
Vice President, Head of Clinical Development
2021-01-01

mark-k-bennett_image

Mark K. Bennett
Mark K. Bennett Senior Vice President @ Calithera Biosciences
Senior Vice President

Founder


susan-m-molineaux_image

Susan M. Molineaux

Stock Details


Company's stock symbol is NASDAQ:CALA

Investors List

the-cystic-fibrosis-foundation_image

Cystic Fibrosis Foundation

Cystic Fibrosis Foundation investment in Grant - Calithera Biosciences

morgenthaler-ventures_image

Morgenthaler Ventures

Morgenthaler Ventures investment in Series D - Calithera Biosciences

delphi-ventures_image

Delphi Ventures

Delphi Ventures investment in Series D - Calithera Biosciences

adage-capital-management_image

Adage Capital Management

Adage Capital Management investment in Series D - Calithera Biosciences

advanced-technology-ventures_image

Advanced Technology Ventures

Advanced Technology Ventures investment in Series D - Calithera Biosciences

longwood-founders-fund_image

Longwood Fund

Longwood Fund investment in Series D - Calithera Biosciences

advanced-technology-ventures_image

Advanced Technology Ventures

Advanced Technology Ventures investment in Series C - Calithera Biosciences

morgenthaler-ventures_image

Morgenthaler Ventures

Morgenthaler Ventures investment in Series C - Calithera Biosciences

delphi-ventures_image

Delphi Ventures

Delphi Ventures investment in Series C - Calithera Biosciences

delphi-ventures_image

Delphi Ventures

Delphi Ventures investment in Venture Round - Calithera Biosciences

Official Site Inspections

http://www.calithera.com

  • Host name: 63.0.153.160.host.secureserver.net
  • IP address: 160.153.0.63
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "Calithera Biosciences"

Calithera Biosciences - Crunchbase Company Profile

Calithera Biosciences is a development-stage pharmaceutical company committed to discovering and developing novel small molecule therapeutics for the treatment of cancer. They are applying Their scientific expertise to build a โ€ฆSee details»

Calithera Company Profile 2024: Valuation, Funding

Calithera Biosciences Inc is a clinical-stage pharmaceutical company. The business activity of the firm functions through the region of the United States. It focuses on discovering and developing small molecule drugs directed against โ€ฆSee details»

Calithera Biosciences, Inc. (CALA): history, ownership, mission, how โ€ฆ

[relinking] Home History Owners Mission How It Works How It Makes Money A Brief History of Calithera Biosciences, Inc. (CALA) Company Formation and Early Years Calithera โ€ฆSee details»

Calithera Biosciences - Craft

Oct 29, 2024 Calithera is currently evaluating CB-839 in three Phase 1 clinical trials in solid and hematological tumors. In tumor immunology, the Company's lead preclinical program is โ€ฆSee details»

Calithera Biosciences - LinkedIn

Calithera Biosciences is a clinical-stage biopharmaceutical company pioneering the discovery and development of targeted therapies that disrupt cellular metabolic pathways to preferentially โ€ฆSee details»

Calithera Biosciences Inc - AnnualReports.com

Calithera Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer in the โ€ฆSee details»

Calithera Biosciences - The Org

Calithera is developing first-in-class small molecule drugs directed against tumor metabolism and tumor immunology targets to treat cancer. Industries. Pharmaceutical. Headquarters. South โ€ฆSee details»

Calithera Biosciences, Inc. (CALA) - Yahoo Finance

See the company profile for Calithera Biosciences, Inc. (CALA) including business summary, industry/sector information, number of employees, business summary, corporate governance, โ€ฆSee details»

Calithera Biosciences Company Description - Stock Analysis

Nov 27, 2024 Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision โ€ฆSee details»

Calithera Biosciences - Funding, Financials, Valuation & Investors

Calithera Biosciences is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.See details»

Calithera Biosciences Information - RocketReach

Calithera Biosciences is a clinical-stage biopharmaceutical company pioneering the discovery and development of targeted therapies that disrupt cellular metabolic pathways to preferentially โ€ฆSee details»

Calithera Biosciences Announces Board Approval of Complete โ€ฆ

Jan 9, 2023 SOUTH SAN FRANCISCO, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), today announced that its Board of Directors has โ€ฆSee details»

10-K - SEC.gov

Dec 31, 2022 Our Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on March 31, 2022, and available free of charge on the SECโ€™s website at โ€ฆSee details»

Calithera Biosciences, Inc. (CALA) - Stock Analysis

Nov 1, 2024 About Calithera Biosciences. Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the โ€ฆSee details»

Calithera Biosciences, Inc. - Cruelty Free Investing

Calithera Biosciences, Inc. is a clinical-stage pharmaceutical company, which focuses on discovering and developing novel small molecule drugs directed against tumor metabolism โ€ฆSee details»

Calitheraโ€™s Competitors, Revenue, Number of Employees ... - Owler

Calitheraโ€™s Profile, Revenue and Employees. Calithera is a California-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of cancer. โ€ฆSee details»

Calithera | Scientist.com

Calithera 343 Oyster Point Boulevard South San Francisco, CA, 94080 United States ... If your organization has a Scientist.com marketplace, you can log in here to order products and โ€ฆSee details»

Calithera Biosciences, Inc. (CALA) - Yahoo Finance Canada

Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology โ€ฆSee details»

Cash-strapped Calithera closes down in wake of enrollment delays

Jan 10, 2023 Calithera Biosciences has kept its head down since a phase 2 fail in 2021 caused layoffs for a third of its workforce. But in the wake of enrollment delays for two lead cancer โ€ฆSee details»

What is Calithera Biosciences? Company Culture, Mission, Values

See what employees say it's like to work at Calithera Biosciences. Salaries, reviews, and more - all posted by employees working at Calithera Biosciences.See details»

linkstock.net © 2022. All rights reserved